RxDoctor Payments Data

Wiley Petersen, PA

Physician Assistant · Fort Hall, IDNPI 1568920080

Payments from drug & device makers

$718in general payments, 2019–2025

Across 39 payments — averaging $18.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$256
  • Novo Nordisk$143
  • Corcept Therapeutics$93
  • Axsome Therapeutics, Inc.$80
  • Lilly USA, LLC$46
  • Boston Scientific$31
  • plus $70 from 4 others

What the payments were for

  • Food & beverage$718100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$718 in reported general payments places this provider in the 65th percentile of 1,027 physician assistant providers in Idaho.

See all physician assistant providers in Idaho

Medicare billing

Part B allowed, 2024
$16,154
Medicare patients
93
Services billed
393

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide33$32,591
JardianceEmpagliflozin14$19,128
EliquisApixaban12$18,604
MounjaroTirzepatide11$13,302
FarxigaDapagliflozin Propanediol16$12,365
Trelegy ElliptaFluticasone/Umeclidin/Vilanter14$8,747
Desvenlafaxine Succinate ErDesvenlafaxine Succinate17$5,299
Lantus SolostarInsulin Glargine,hum.Rec.Anlog24$1,970
Testosterone Cypionate25$1,668
ProgesteroneProgesterone, Micronized25$1,095
Levothyroxine Sodium115$1,042
Celecoxib13$1,039
Albuterol Sulfate HfaAlbuterol Sulfate41$1,007
Quetiapine Fumarate24$863
Potassium Chloride19$813

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$143$32,59133 claims
Lilly USA, LLCMounjaro$46$13,30211 claims
GSKTrelegy Ellipta$18$8,74714 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,027 physician assistant providers in Idaho.

Other physician assistant in Fort Hall

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →